Nextwave Pharmaceuticals, Inc drugs

4 results

  • dyanavel xr - amphetamine suspension, extended release

    (Amphetamine)
    Nextwave Pharmaceuticals, Inc
    DYANAVEL XR treats Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older. Not recommended for children under 6 due to higher plasma exposure and adverse reactions.
    Medication Details
    Drug Interactions

  • quillichew er - methylphenidate hydrochloride tablet, chewable, extended release

    (Methylphenidate Hydrochloride)
    Nextwave Pharmaceuticals, Inc
    QuilliChew ER treats Attention Deficit Hyperactivity Disorder (ADHD). Not recommended for children under 6 years old due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions

  • quillivant xr - methylphenidate hydrochloride suspension, extended release

    (Methylphenidate Hydrochloride)
    Nextwave Pharmaceuticals, Inc
    Quillivant XR treats Attention Deficit Hyperactivity Disorder (ADHD). Not recommended for children under 6 years old due to higher drug exposure and increased risk of adverse reactions such as weight loss.
    Medication Details
    Drug Interactions